Catalyst Wire Dossier Catalyst Wire Dossier

AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05%

azelastine hydrochloride ophthalmic solution 0.05% · Alembic Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05%, covering 2019-03-20 to 2019-03-20. Get the full timeline:

Most recent: FDA Approved: AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05% — Original Application (Alembic Pharmaceuticals Inc.)

See pricing